Multidisciplinary Management of the patient with T2D and CKD 1-2

Feb 14, 2023 | CARDIORENAL

2) This #accredited #tweetorial series on #kidneydisease #CKD is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based based HCPs. Accreditation statement & faculty disclosures at...

Risk Stratification: Identifying the Patient with T2D and DKD Most at Risk for Rapid Progression to Advanced CKD

Feb 6, 2023 | CARDIORENAL

2) This #accredited #tweetorial series on #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.— cardio-met (@cardiomet_CE) February 7,...

The Sleeping Giant:  Type 2 Diabetes & Sleep Disorders

Jan 2, 2023 | CARDIORENAL

2) Our expert faculty is Dr Kevin Fernando @drkevinfernando, FRCGP FRCP Edin, FAcadMEd MSc Diabetes, GP with Specialist Interest in CVRM & Medical Education. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm....

AHA2022 UPDATE: META-ANALYSIS INDICATES SGLT2i SHOULD BE FOUNDATIONAL THERAPY IN CKD

Dec 28, 2022 | CARDIORENAL

2) This work was presented by Will Herrington @willkidney, @The_MRC @Kidney_Research UK funded AssocProf @Oxford_NDPH and representing the contributions of 241 participating sites from 8 countries 🌎🌍. EMPA-KIDNEY was funded and sponsored by Boehringer...

Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Persons with Diabetes: PART C

Dec 5, 2022 | CARDIORENAL

PART C: Strategies to Optimize Treatment Plans and Educate Persons with Diabetes 53) We are honored to have 2 #pharmacists and 1 #nutritionist guide us through the complex and vitally important topic, which was addressed from the physician perspective by @RpratleyMD...

Treatment Strategies for Basal Insulins to Manage Time-in-Range and Glucose Variability to Improve Outcomes in Persons with Diabetes: PART B

Dec 5, 2022 | CARDIORENAL

Part B: Clinical Review of Newer Longer-acting Insulins in Persons with Diabetes  28) We are honored to have 2 pharmacists and 1 nutritionist guide us through the complex and vitally important topic, which was addressed from the physician perspective by @RpratleyMD...